Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients

Study ID
NCT00964457

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

Trial Summary

response rate to adding cetuximab, oxaliplatin and capecitabine to radiation for advanced rectum cancer

More informations

Trial Starting Date

Aug 31,2009

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit